{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:04:15Z","timestamp":1790820255782,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.semcancer.2020.10.008","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:11:22Z","timestamp":1610662282000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine"],"prefix":"10.1016","volume":"72","author":[{"given":"R.","family":"Bonfiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2020.10.008_bib0005","series-title":"Breast Cancer: Prevention and Control","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0010","series-title":"Breast Cancer Statistics","author":"World Cancer Research Fund","year":"2021"},{"issue":"1","key":"10.1016\/j.semcancer.2020.10.008_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09513590.2015.1078304","article-title":"Progestogens and risk of breast cancer: a link between bone and breast?","volume":"32","author":"Gonz\u00e1lez Ricarte","year":"2016","journal-title":"Gynecol. Endocrinol."},{"issue":"September (9)","key":"10.1016\/j.semcancer.2020.10.008_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5732\/cjc.011.10226","article-title":"Epithelial-mesenchymal transition in breast cancer progression and metastasis","volume":"30","author":"Wang","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0036-1572546","article-title":"The current status of oral contraceptives: progress and recent innovations","volume":"34","author":"Golobof","year":"2016","journal-title":"Semin. Reprod. Med."},{"issue":"December","key":"10.1016\/j.semcancer.2020.10.008_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","article-title":"Trends and predictions to 2020 in breast cancer mortality in Europe","volume":"36","author":"Carioli","year":"2017","journal-title":"Breast"},{"issue":"June (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12905-019-0770-x","article-title":"Oral contraceptive and breast cancer: do benefits outweigh the risks? A case - control study from Jordan","volume":"19","author":"Bardaweel","year":"2019","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.semcancer.2020.10.008_bib0040","article-title":"The Impact of the natural, social, built, and policy environments on breast cancer","volume":"1","author":"Coughlin","year":"2015","journal-title":"J. Environ. Health Sci."},{"issue":"July-August (4)","key":"10.1016\/j.semcancer.2020.10.008_bib0045","first-page":"193","article-title":"The role of diet, physical activity, body fatness, and breastfeeding in breast Cancer in young women: epidemiological evidence","volume":"69","author":"Romieu","year":"2017","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0050","series-title":"A Quick Guide to Cancer Epidemiology","first-page":"46","author":"Boffetta","year":"2014"},{"issue":"February (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-2852-7","article-title":"Reproductive risk factors and breast cancer subtypes: a review of the literature","volume":"144","author":"Anderson","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"April","key":"10.1016\/j.semcancer.2020.10.008_bib0060","article-title":"New advances in molecular breast cancer pathology","volume":"5","author":"Rakha","year":"2020","journal-title":"FG.Semin Cancer Biol."},{"issue":"16","key":"10.1016\/j.semcancer.2020.10.008_bib0065","first-page":"1679","article-title":"Molecular basis of metastasis","volume":"360","author":"Batistatou","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.semcancer.2020.10.008_bib0070","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"June (16)","key":"10.1016\/j.semcancer.2020.10.008_bib0075","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"October (7418)","key":"10.1016\/j.semcancer.2020.10.008_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas. Network","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2020.10.008_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4132\/jptm.2019.11.03","article-title":"HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation","volume":"54","author":"Ahn","year":"2020","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fonc.2017.00110","article-title":"Estrogen effects on the mammary gland in early and late life and breast cancer risk","volume":"7","author":"Dall","year":"2017","journal-title":"Front. Oncol."},{"issue":"August (4)","key":"10.1016\/j.semcancer.2020.10.008_bib0095","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.clbc.2017.11.020","article-title":"Breast osteoblast-like cells: a reliable early marker for bone metastases from breast cancer","volume":"18","author":"Scimeca","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.10.008_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/emph\/eox009","article-title":"Oral contraceptives cause evolutionarily novel increases in hormone exposure","volume":"2017","author":"Lovett","year":"2017","journal-title":"Risk Factor Breast Cancer Evol Med Public Health."},{"issue":"July (4)","key":"10.1016\/j.semcancer.2020.10.008_bib0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr3166","article-title":"Nodes during mammary gland development","volume":"14","author":"Tanos","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2011.10.030","article-title":"The biology of progesterone receptor in the normal mammary gland and in breast cancer","volume":"357","author":"Obr","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"December (12)","key":"10.1016\/j.semcancer.2020.10.008_bib0115","first-page":"a003178","article-title":"Hormone action in the mammary gland","volume":"2","author":"Brisken","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"November","key":"10.1016\/j.semcancer.2020.10.008_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2018.03.057","article-title":"The action of estrogens and progestogens in the young female breast","volume":"230","author":"Zolfaroli","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"June (1-2)","key":"10.1016\/j.semcancer.2020.10.008_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10911-015-9337-0","article-title":"Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy","volume":"20","author":"Arendt","year":"2015","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0130","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.0915148107","article-title":"Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland","volume":"107","author":"Beleut","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"June (7299)","key":"10.1016\/j.semcancer.2020.10.008_bib0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2012","journal-title":"Lancet Oncol."},{"issue":"September (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12940-017-0287-4","article-title":"State of the evidence 2017: an update on the connection between breast cancer and the environment","volume":"16","author":"Gray","year":"2017","journal-title":"Environ. Health"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","article-title":"Mechanisms of endocrine resistance in breast cancer","volume":"62","author":"Osborne","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"September (10)","key":"10.1016\/j.semcancer.2020.10.008_bib0155","first-page":"1009","article-title":"Sex hormones and breast cancer risk in premenopausal women: collaborative reanalysis of seven prospective studies","volume":"14","author":"Endogenous Hormones and Breast Cancer Collaborative Group","year":"2013","journal-title":"Lancet Oncol."},{"issue":"July (Pt A)","key":"10.1016\/j.semcancer.2020.10.008_bib0160","first-page":"49","article-title":"Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies","volume":"99","author":"Key","year":"2015","journal-title":"Steroids"},{"issue":"November (22)","key":"10.1016\/j.semcancer.2020.10.008_bib0165","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"June (25)","key":"10.1016\/j.semcancer.2020.10.008_bib0170","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"NCIC CTG MAP.3 Study Investigators. Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"November (7320)","key":"10.1016\/j.semcancer.2020.10.008_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"issue":"August (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0180","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-014-3049-9","article-title":"RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase","volume":"146","author":"Hu","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0039-128X(00)00195-1","article-title":"Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer","volume":"65","author":"Klijn","year":"2000","journal-title":"Steroids"},{"issue":"September (7621)","key":"10.1016\/j.semcancer.2020.10.008_bib0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"March (11)","key":"10.1016\/j.semcancer.2020.10.008_bib0195","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.2018.0448","article-title":"Weighing the risks and benefits of hormonal contraception","volume":"319","author":"Peachman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0200","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"issue":"June (26)","key":"10.1016\/j.semcancer.2020.10.008_bib0205","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptive formulation and risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"November (11)","key":"10.1016\/j.semcancer.2020.10.008_bib0210","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish women\u2019s lifestyle and health cohort study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"October (10)","key":"10.1016\/j.semcancer.2020.10.008_bib0215","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.08.007","article-title":"Oral contraceptive formulation and risk of breast cancer","volume":"85","author":"Marchbanks","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0225","first-page":"1","article-title":"Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy","volume":"91","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0230","first-page":"1","article-title":"Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy","volume":"91","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0235","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.08.007","article-title":"Oral contraceptive formulation and risk of breast cancer","volume":"85","author":"Marchbanks","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0240","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","article-title":"Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age","volume":"74","author":"Beaber","year":"2014","journal-title":"Cancer Res."},{"issue":"June (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"December (23)","key":"10.1016\/j.semcancer.2020.10.008_bib0250","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"October (10)","key":"10.1016\/j.semcancer.2020.10.008_bib0255","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"January (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0260","first-page":"65","article-title":"A prospective study of oral contraceptive use and risk of breast cancer (Nurses\u2019 Health Study, United States)","volume":"8","author":"Hankinson","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"January (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1559827618754833","article-title":"Hormonal contraception and breast cancer risk","volume":"12","author":"White","year":"2018","journal-title":"Am. J. Lifestyle Med."},{"issue":"June (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0270","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/09513590.2019.1576610","article-title":"Hormonal contraception and risk of breast cancer: a critical look","volume":"35","author":"Barriga","year":"2019","journal-title":"Gynecol. Endocrinol."},{"issue":"September (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.contraception.2018.05.002","article-title":"Hormonal contraception and breast cancer","volume":"98","author":"Westhoff","year":"2018","journal-title":"Contraception"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0280","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 oral contraception study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"March (13)","key":"10.1016\/j.semcancer.2020.10.008_bib0285","first-page":"1263","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"378","author":"Schwarz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"March","key":"10.1016\/j.semcancer.2020.10.008_bib0290","doi-asserted-by":"crossref","first-page":"102876","DOI":"10.1016\/j.critrevonc.2020.102876","article-title":"Riccardo Masetti Oral contraceptives and breast cancer risk: an overestimated risk?","volume":"147","author":"Franceschini","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"March (13)","key":"10.1016\/j.semcancer.2020.10.008_bib0295","first-page":"1265","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"378","author":"M\u00f8rch","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"December (23)","key":"10.1016\/j.semcancer.2020.10.008_bib0300","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMe1709636","article-title":"Oral contraceptives and the small increased risk of breast cancer","volume":"377","author":"Hunter","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"May (5)","key":"10.1016\/j.semcancer.2020.10.008_bib0305","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women","volume":"23","author":"Beaber","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"August (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0310","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J. Clin. Oncol."},{"issue":"January (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/fon-2017-0472","article-title":"Bonanno Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis","volume":"14","author":"Scimeca","year":"2018","journal-title":"Future Oncol."},{"issue":"April 14","key":"10.1016\/j.semcancer.2020.10.008_bib0320","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2407-14-286","article-title":"Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics","volume":"23","author":"Scimeca","year":"2014","journal-title":"BMC Cancer"},{"issue":"December (30)","key":"10.1016\/j.semcancer.2020.10.008_bib0325","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.2217\/fon-2018-0624","article-title":"Breast microcalcifications: biological and diagnostic perspectives","volume":"14","author":"Bonfiglio","year":"2018","journal-title":"Future Oncol."},{"issue":"June (1-2)","key":"10.1016\/j.semcancer.2020.10.008_bib0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-018-9396-0","article-title":"Radiological, histological and chemical analysis of breast microcalcifications: diagnostic value and biological significance","volume":"23","author":"Bonfiglio","year":"2018","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"November (22)","key":"10.1016\/j.semcancer.2020.10.008_bib0335","article-title":"Microcalcifications drive breast Cancer occurrence and development by macrophage-mediated epithelial to mesenchymal transition","volume":"20","author":"Scimeca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"June (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0340","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3390\/cells9061381","article-title":"BMP-2 variants in breast epithelial to mesenchymal transition and microcalcifications origin","volume":"9","author":"Scimeca","year":"2020","journal-title":"Cells"},{"issue":"April (4)","key":"10.1016\/j.semcancer.2020.10.008_bib0345","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1007\/s13277-015-4361-7","article-title":"Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers","volume":"37","author":"Scimeca","year":"2016","journal-title":"Tumour Biol."},{"issue":"February","key":"10.1016\/j.semcancer.2020.10.008_bib0350","article-title":"Bonanno E.BReast cancer metastasis to bone: from epithelial to mesenchymal transition to breast osteoblast-like cells","volume":"8","author":"Scimeca","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"October (9)","key":"10.1016\/j.semcancer.2020.10.008_bib0355","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41416-018-0255-y","article-title":"Breast osteoblast-like cells: a new biomarker for the management of breast cancer","volume":"119","author":"Scimeca","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2020.10.008_bib0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10911-015-9337-0","article-title":"Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy","volume":"20","author":"Arendt","year":"2015","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"April","key":"10.1016\/j.semcancer.2020.10.008_bib0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.matbio.2015.02.008","article-title":"Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells","volume":"43","author":"Bouris","year":"2015","journal-title":"Matrix Biol."},{"issue":"September Suppl 1","key":"10.1016\/j.semcancer.2020.10.008_bib0370","first-page":"31","article-title":"Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts","volume":"1173","author":"Imai","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"May (5)","key":"10.1016\/j.semcancer.2020.10.008_sbref0375a","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tem.2011.02.007","article-title":"RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis","volume":"22","author":"Schramek","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"April","key":"10.1016\/j.semcancer.2020.10.008_sbref0375b","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2016.01.001","article-title":"Role of the RANK\/RANKL pathway in breast cancer","volume":"86","author":"Kiesel","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0380","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006037823178","article-title":"Use of oral contraceptives and risk of breast cancer in young women","volume":"50","author":"Ursin","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2020.10.008_bib0385","first-page":"1","article-title":"Breast cancer and hormonal contraceptives: further results","volume":"54","author":"EE","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.semcancer.2020.10.008_bib0390","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"September (36)","key":"10.1016\/j.semcancer.2020.10.008_bib0395","first-page":"e15719","article-title":"Effect of age at first use of oral contraceptives on breast cancer risk: an updated meta-analysis","volume":"98","author":"Ji","year":"2019","journal-title":"Bull. Sch. Med. Md"},{"issue":"May-June (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0400","first-page":"186","article-title":"Priorities for the primary prevention of breast cancer","volume":"64","author":"Colditz","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"March (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0405","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrclinonc.2010.227","article-title":"Predictive, personalized, preventive, participatory (P4) cancer medicine","volume":"8","author":"Hood","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"October (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0410","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.11307","article-title":"Oral contraceptive use and risk of breast cancer by histologic type","volume":"106","author":"Newcomer","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","article-title":"Hormonal content and potency of oral contraceptives and breast cancer risk among young women","volume":"88","author":"Althuis","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"July (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0420","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.11167","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"November (9)","key":"10.1016\/j.semcancer.2020.10.008_bib0425","first-page":"1059","article-title":"Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study","volume":"16","author":"Silvera","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"March (2)","key":"10.1016\/j.semcancer.2020.10.008_bib0430","first-page":"189","article-title":"Risk of breast cancer associated with short-term use of oral contraceptives","volume":"18","author":"Folger","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"February (4)","key":"10.1016\/j.semcancer.2020.10.008_bib0435","first-page":"473","article-title":"A case-control study of oral contraceptive use and incident breast cancer","volume":"169","author":"Rosenberg","year":"2009","journal-title":"Am. J. Epidemiol."},{"issue":"August (12)","key":"10.1016\/j.semcancer.2020.10.008_bib0440","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"August (8)","key":"10.1016\/j.semcancer.2020.10.008_bib0445","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1586\/era.11.38","article-title":"Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis","volume":"11","author":"Cibula","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"December (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0450","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/13625187.2012.715357","article-title":"Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies","volume":"17","author":"Zhu","year":"2012","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"May (9)","key":"10.1016\/j.semcancer.2020.10.008_bib0455","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-156-9-201205010-00006","article-title":"Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis","volume":"156","author":"Nelson","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"November (33)","key":"10.1016\/j.semcancer.2020.10.008_bib0460","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"September (5)","key":"10.1016\/j.semcancer.2020.10.008_bib0465","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1010539513488795","article-title":"Risk factors of breast cancer: a systematic review and meta-analysis","volume":"25","author":"Anothaisintawee","year":"2013","journal-title":"Asia. J. Public Health"},{"issue":"December (3)","key":"10.1016\/j.semcancer.2020.10.008_bib0470","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2015.05.026","article-title":"Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death","volume":"131","author":"Zhong","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"January (2)","key":"10.1016\/j.semcancer.2020.10.008_bib0475","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10549-014-3252-8","article-title":"History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response","volume":"149","author":"Huzell","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"January (1)","key":"10.1016\/j.semcancer.2020.10.008_bib0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10549-015-3663-1","article-title":"Progestin and breast cancer risk: a systematic review","volume":"155","author":"Samson","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"June (6)","key":"10.1016\/j.semcancer.2020.10.008_bib0485","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 oral contraception study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"November (11)","key":"10.1016\/j.semcancer.2020.10.008_bib0490","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/GME.0000000000001217","article-title":"Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy","volume":"25","author":"Brinton","year":"2018","journal-title":"Menopause"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20302133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20302133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:47:02Z","timestamp":1760917622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X20302133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":99,"alternative-id":["S1044579X20302133"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.10.008","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}